全球藥物溶出測試服務市場—規模,份額和趨勢分析：按方法（體外/體內）,劑型（膠囊,片劑）,溶出裝置（籃,槳）,地區預測2023-2030

全球藥物溶出服務市場規模預計到 2030 年將達到 12 億美元，2023 年至 2030 年的複合年增長率為 8.0%。

藥物開發流程的改進、技術的不斷進步以及對優質產品需求意識的增強正在推動市場的增長。

本報告研究了全球藥物溶出服務市場，並提供了全面的信息，包括市場前景、市場分析和競爭格局。

內容

第一章調查方法及範圍

• 市場細分和範圍
  • 細分範圍
  • 區域範圍
• 調查方法
• 信息採購
  • 購買的數據庫
  • GVR 內部數據庫
  • 次要信息
  • 初步調查
  • 初步調查的詳細信息
• 信息或數據分析
  • 數據分析模型
• 市場製定和驗證
• 模型詳細信息
  • 商品流分析
    • 方法：產品流方法
• 調查假設
• 二級信息列表
• 縮寫列表
• 目的

第 2 章執行摘要

• 市場前景
• 細分市場展望
• 競爭洞察力

第 3 章藥物溶出測試服務市場變量、趨勢和範圍

• 市場系列展望
  • 母公司市場展望
  • 輔助市場展望
• 描繪滲透率和增長前景
• 市場動態
  • 市場驅動因素分析
    • 增加研發活動
    • 由於慢性病和傳染病的負擔增加，對藥物溶出度測試的需求增加
    • 增加仿製藥的使用
  • 市場製約因素分析
    • 加大方法驗證力度
• 藥物溶出度測試服務：市場分析工具
  • 行業分析：波特五力分析
  • PESTEL 分析
  • 主要交易和戰略聯盟
  • COVID-19 影響分析

第 4 章藥物溶出測試服務市場：細分分析（百萬美元）（2018-2030）：按方法

• 定義和範圍
• 方法市場份額分析（2022 年和 2030 年）
  • 體外
  • 體內

第 5 章藥物溶解服務市場：細分分析（百萬美元）（2018-2030）：按配方分類

• 定義和範圍
• 劑型市場份額分析（2022 年和 2030 年）
  • 膠囊
  • 藥丸
  • 其他

第 6 章藥物溶出測試服務市場：細分分析（百萬美元）（2018-2030）： 通過洗脫裝置

• 定義和範圍
• 洗脫設備市場份額分析（2022 年和 2030 年）
  • 籃子
  • 槳
  • 其他

第 7 章藥物溶出測試服務市場：細分分析（百萬美元）（2018-2030）：按地區

• 定義和範圍
• 區域市場份額分析（2022 年和 2030 年）
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 8 章藥物溶出測試服務市場：競爭分析

• 公司簡介
  • Intertek Group Plc
  • Avivia BV
  • Almac Group
  • Agilent Technologies, Inc.
  • Catalent, Inc.
  • Thermofisher Scientific Inc.
  • Charles River Laboratories
  • Cambrex
  • Boston Analytical
  • SOTAX
  • SGS SA
  • AMRI
  • Pace Analytical Life Sciences

Pharmaceutical Dissolution Testing Services Market Growth & Trends:

The global pharmaceutical dissolution testing services market size is expected to reach USD 1.2 billion by 2030, registering a CAGR of 8.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to increase primarily as a result of the rising drug development process, increasing technological advancements, rising awareness about the need for high-quality products, and the production of numerous medications for various chronic diseases that require dissolution testing. The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs.

Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms. And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.

Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient's system and whether any negative effects brought on by slower absorption rates would occur. Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.

Pharmaceutical Dissolution Testing Services Market Report Highlights:

• The in vitro method segment accounted for the largest revenue share in 2022

• The tablets dosage form segment accounted for the largest share and is anticipated to grow at the fastest CAGR during the forecast period

• Tablets have high physical and chemical stability and the amount of drug delivered to the body can be controlled

• Based on dissolution apparatus, the paddle segment dominated the industry in 2022 as it can cover a range of oral dosage forms

• North America dominated the industry in 2022 owing to rising investments by public firms in research and their state-of-the-art research infrastructure

Table of Content

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Pharmaceutical Dissolution Testing Services Market Variables, Trends, and Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Drivers Analysis
    • 3.3.1.1 Increasing R&D activities
    • 3.3.1.2 Rising burden of chronic and infectious diseases supporting demand for dissolution testing of drugs
    • 3.3.1.3 Rising use of generic drugs
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 Increased effort for method validation
• 3.4 Pharmaceutical Dissolution Testing Services: Market Analysis Tools
  • 3.4.1 Industry Analysis: Porter's Five Forces
  • 3.4.2 PESTEL Analysis
  • 3.4.3 Major Deals And Strategic Alliances
  • 3.4.4 COVID- 19 Impact Analysis

Chapter 4 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Method Market Share Analyses, 2022 & 2030
  • 4.2.1 In-vitro
    • 4.2.1.1 In-vitro market, 2018 - 2030 (USD Million)
  • 4.2.2 In-vivo
    • 4.2.2.1 In-vivo market, 2018 - 2030 (USD Million)

Chapter 5 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Dosage Form Market Share Analysis, 2022 & 2030
  • 5.2.1 Capsules
    • 5.2.1.1 Capsules market, 2018 - 2030 (USD Million)
  • 5.2.2 Tablets
    • 5.2.2.1 Tablets market, 2018 - 2030 (USD Million)
  • 5.2.3 Others
    • 5.2.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Dissolution Apparatus, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Dosage Form Market Share Analysis, 2022 & 2030
  • 6.2.1 Basket
    • 6.2.1.1 Basket market, 2018 - 2030 (USD Million)
  • 6.2.2 Paddle
    • 6.2.2.1 Paddle market, 2018 - 2030 (USD Million)
  • 6.2.3 Others
    • 6.2.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 Pharmaceutical Dissolution Testing Services Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.2.1 North America
    • 7.2.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.2.1.2 U.S.
    • 7.2.1.2.1 U.S. pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.1.3 Canada
    • 7.2.1.2.1 Canada pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
  • 7.2.2 Europe
    • 7.2.2.1 Europe pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.2.2 U.K.
    • 7.2.2.2.1 U.K. pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.2.3 Germany
    • 7.2.2.3.1 Germany pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.2.4 Spain
    • 7.2.2.4.1 Spain pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.2.5 France
    • 7.2.2.5.1 France pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.2.6 Italy
    • 7.2.2.6.1 Italy pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
  • 7.2.3 Asia Pacific
    • 7.2.3.1 Asia Pacific pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.3.2 Japan
    • 7.2.3.2.1 Japan pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.3.3 China
    • 7.2.3.3.1 China pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.3.4 India
    • 7.2.3.4.1 India pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.3.5 South Korea
    • 7.2.3.5.1 South Korea pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.3.7 Australia
    • 7.2.3.7.1 Australia pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
  • 7.2.4 Latin America
    • 7.2.4.1 Latin America pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.4.2 Brazil
    • 7.2.4.2.1 Brazil pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.4.3 Mexico
    • 7.2.4.3.1 Mexico pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.4.4 Argentina
    • 7.2.4.4.1 Argentina pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
  • 7.2.5 MEA
    • 7.2.5.1 MEA pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.5.2 South Africa
    • 7.2.5.2.1 South Africa pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.5.3 Saudi Arabia
    • 7.2.5.3.1 Saudi Arabia pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)
    • 7.2.5.4 UAE
    • 7.2.5.4.1 UAE pharmaceutical dissolution testing services market, 2018 - 2030 (USD Million)

Chapter 8 Pharmaceutical Dissolution Testing Services Market: Competitive Analysis

• 8.1 Company Profiles
  • 8.1.1 Intertek Group Plc
    • 8.1.1.1 Company overview
    • 8.1.1.2 Financial performance
    • 8.1.1.3 Product benchmarking
    • 8.1.1.4 Strategic initiatives
  • 8.1.2 Avivia BV
    • 8.1.2.1 Company overview
    • 8.1.2.2 Financial performance
    • 8.1.2.3 Product benchmarking
    • 8.1.2.4 Strategic initiatives
  • 8.1.3 Almac Group
    • 8.1.3.1 Company overview
    • 8.1.3.2 Financial performance
    • 8.1.3.3 Product benchmarking
    • 8.1.3.4 Strategic initiatives
  • 8.1.4 Agilent Technologies, Inc.
    • 8.1.4.1 Company overview
    • 8.1.4.2 Financial performance
    • 8.1.4.3 Product benchmarking
    • 8.1.4.4 Strategic initiatives
  • 8.1.5 Catalent, Inc.
    • 8.1.5.1 Company overview
    • 8.1.5.2 Financial performance
    • 8.1.5.3 Product benchmarking
    • 8.1.5.4 Strategic initiatives
  • 8.1.6 Thermofisher Scientific Inc.
    • 8.1.6.1 Company overview
    • 8.1.6.2 Financial performance
    • 8.1.6.3 Product benchmarking
    • 8.1.6.4 Strategic initiatives
  • 8.1.7 Charles River Laboratories
    • 8.1.7.1 Company overview
    • 8.1.7.2 Financial performance
    • 8.1.7.3 Product benchmarking
    • 8.1.7.4 Strategic initiatives
  • 8.1.8 Cambrex
    • 8.1.8.1 Company overview
    • 8.1.8.2 Financial performance
    • 8.1.8.3 Product benchmarking
    • 8.1.8.4 Strategic initiatives
  • 8.1.9 Boston Analytical
    • 8.1.9.1 Company overview
    • 8.1.9.2 Financial performance
    • 8.1.9.3 Product benchmarking
    • 8.1.9.4 Strategic initiatives
  • 8.1.10 SOTAX
    • 8.1.10.1 Company overview
    • 8.1.10.2 Financial performance
    • 8.1.10.3 Product benchmarking
    • 8.1.10.4 Strategic initiatives
  • 8.1.11 SGS SA
    • 8.1.11.1 Company overview
    • 8.1.11.2 Financial performance
    • 8.1.11.3 Product benchmarking
    • 8.1.11.4 Strategic initiatives
  • 8.1.12 AMRI
    • 8.1.12.1 Company overview
    • 8.1.12.2 Financial performance
    • 8.1.12.3 Product benchmarking
    • 8.1.12.4 Strategic initiatives
  • 8.1.13 Pace Analytical Life Sciences
    • 8.1.13.1 Company overview
    • 8.1.13.2 Financial performance
    • 8.1.13.3 Product benchmarking
    • 8.1.13.4 Strategic initiative

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market summary, 2022
• Fig. 5 Market trends & outlook
• Fig. 6 Market segmentation & scope
• Fig. 7 Market driver relevance analysis (Current & future impact)
• Fig. 8 Market restraint relevance analysis (Current & future impact)
• Fig. 9 Penetration & growth prospect mapping
• Fig. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Pharmaceutical Dissolution Testing Services market: Key takeaways, by method (USD Million)
• Fig. 13 In vitro market revenue estimates and forecast 2018 - 2030 (USD Million)
• Fig. 14 In vivo market revenue estimates and forecast 2018 - 2030 (USD Million)
• Fig. 15 Pharmaceutical Dissolution Testing Services market: Dosage form movement analysis, 2021 & 2030 (USD Million)
• Fig. 16 Capsule market revenue estimates and forecast 2018 - 2030 (USD Million)
• Fig. 17 Tablets market revenue estimates and forecast 2018 - 2030 (USD Million)
• Fig. 18 Others market revenue estimates and forecast 2018 - 2030 (USD Million)
• Fig. 19 Regional marketplace: Key takeaways (USD Million)
• Fig. 20 Regional outlook, 2022 & 2030 (USD Million)
• Fig. 21 North America Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 22 U.S. Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 23 Canada Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 24 Europe Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 25 U.K. Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 26 Germany Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 27 France Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 28 Italy Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 29 Spain Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 30 Asia Pacific Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 31 China Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 32 Japan Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 33 India Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 34 South Korea Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 35 Australia Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 36 Latin America Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 37 Brazil Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 38 Mexico Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 39 Argentina Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 40 MEA Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 41 South Africa Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 42 Saudi Arabia Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 43 UAE Pharmaceutical Dissolution Testing Services market revenue estimates and forecasts 2018 - 2030 (USD Million)